Document
·
By
admin admin
On
Dec 8, 19, 12:56 AM
Come è la qualitÃ
dell’informazione sul
controllo non farmacologico
della colesterolemia nel
nostro Paese?
• Gli acidi grassi omega-3, secondo molti
messaggi pubblicitari, abbassano la ...
Document
·
By
Stefano Pesarin
On
Oct 17, 25, 10:38 AM
Anno di
riferimento
del
Pagamento
Trimestre
Categoria
di spesa
Tipologia di spesa Importo Beneficiario
2025 3
uscite
correnti
Contributi in conto
esercizio 9.116.104,25
...
Document
·
By
Edoardo Di Matteo
On
Jan 30, 26, 2:57 PM
Anno di
riferimento
del
Pagamento
Trimestre
Categoria di
spesa
Tipologia di spesa Importo Beneficiario
2025 IV uscite correnti Acquisto di beni e di servizi 489,00...
Document
·
By
Edoardo Di Matteo
On
Jul 24, 25, 4:06 PM
Anno di
riferimento
del
Pagamento
Trimestre
Categoria
di spesa
Tipologia di spesa Importo Beneficiario
2025 2
Uscite
c/capitale
Investimenti in beni
materiali 59.780,00...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 7, 19, 11:14 AM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 6, 19, 11:33 PM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 5, 19, 11:15 PM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 5, 19, 11:34 PM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 5, 19, 11:23 PM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 6, 19, 12:06 AM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 6, 19, 11:50 PM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 6, 19, 11:22 PM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
Document
·
By
admin admin
On
Dec 6, 19, 12:18 AM
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
IATRIS contribution to
product development
Discovery Pre-Clin Phase I Phase II
IATRIS
Target
Valid.
Validation
in vivo
GMP
Synthesis
& Optimiz.
ToxicologyScreening Phase IIaPhase I
...
